Search IPOs
NEPHROPLUS
Nephrocare Health IPO, a Mainboard IPO was listed on the exchange on December 17, 2025. The price band is set between ₹438 –460 , with a face value of ₹2 . Retail investors can apply with a minimum of 1 lot, each comprising 32 shares — amounting to ₹14,720 at the upper price.
Nephrocare Health IPO has been successfully listed on the exchange. Track the listing performance, current stock price, and post-listing trends. This information is for education only—not investment advice.
Nephrocare Health IPO MAINBOARD Important Dates
Get important updates regarding Nephrocare Health IPO MAINBOARD tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates. Dates are updated as soon as they are announced.
Listing day gain
+6.52%
Listed at ₹490 (issue ₹460)
Issue
₹460
Listing
₹490
Current
₹471.25
+2.45% vs issue
Day range
₹463.8 – ₹499
Open Date
Dec 10
Close Date
Dec 12
Allotment
Dec 15
Listing
Dec 17
Issue Size
₹871.04 Cr
Issue Price
₹438 – ₹460
Face Value
₹2/share
Market Lot
32 shares
Retail Min Investment
₹14,720
Listing At
NSE,BSE
Sale Type
both
Fresh Issue
₹353.4 Cr
Offer for Sale
₹517.64 Cr
Issue Type
book building
Last updated: 3 months ago
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 17 Dec 2025 Latest | ₹460 | ₹40 | ₹500 | ₹40 |
8.7%
|
12:00 PM |
| 16 Dec 2025 | ₹460 | ₹37 | ₹497 | ₹37 |
8.04%
|
12:00 PM |
| 15 Dec 2025 | ₹460 | ₹37 | ₹497 | ₹37 |
8.04%
|
12:00 PM |
| 14 Dec 2025 | ₹460 | ₹34.5 | ₹494.5 | ₹34.5 |
7.5%
|
12:00 PM |
| 13 Dec 2025 | ₹460 | ₹33 | ₹493 | ₹33 |
7.17%
|
12:00 PM |
| 12 Dec 2025 | ₹460 | ₹33 | ₹493 | ₹33 |
7.17%
|
12:00 PM |
| 11 Dec 2025 | ₹460 | ₹11.5 | ₹471.5 | ₹11.5 |
2.5%
|
12:00 PM |
| 10 Dec 2025 | ₹460 | ₹20 | ₹480 | ₹20 |
4.35%
|
12:00 PM |
Latest snapshot: Dec 17, 2025
| Category | Subscribed (x) |
|---|---|
| QIB | 16.01x |
| NII | 17.87x |
| bNII (bids above ₹10L) | 22.01x |
| sNII (bids below ₹10L) | 9.58x |
| Retail Investors | 1.68x |
| Total | 9.15x |
IPO investment limits, also referred to as application limits or bidding limits, define the minimum and maximum number of shares, lots, and investment amount that investors can apply for in an IPO based on their category (Retail, HNI, or Institutional). These limits are calculated as per SEBI guidelines and help ensure fair distribution of shares. Retail investors typically have lower minimum and maximum limits compared to High Net Worth Individuals (HNI) and Non-Institutional Investors (NII). Understanding IPO application limits is essential for investors to determine how much they can invest, calculate the number of lots they can apply for, and plan their investment strategy accordingly. The investment limits table shows the lot size, number of shares, and total amount in rupees for each investor category.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 32 | ₹14,720 |
| Retail (Max) | 13 | 416 | ₹191,360 |
| S-HNI (Min) | 14 | 448 | ₹206,080 |
| S-HNI (Max) | 67 | 2,144 | ₹986,240 |
| B-HNI (Min) | 68 | 2,176 | ₹1,000,960 |
The IPO reservation structure, also known as share allocation breakdown, details how the total issue size is distributed among different investor categories as mandated by SEBI (Securities and Exchange Board of India) regulations. This reservation table shows the exact percentage and number of shares allocated to Qualified Institutional Buyers (QIB), Retail Individual Investors (RII), High Net Worth Individuals (HNI), Non-Institutional Investors (NII), and other reserved categories like employees and shareholders. Understanding IPO reservation percentages is crucial for investors to evaluate their probability of share allotment, as each category has different subscription levels and competition. The maximum allottees column indicates the cap on the number of investors who can receive shares in each category, helping you assess the likelihood of getting an allotment based on your investor category.
| Category | Shares Offered |
|---|---|
| QIB Shares Offered | 9,620,900 |
| Total Shares Offered | 9,620,900 |
Nephrocare Health Services, operating under the brand NephroPlus, is India’s and Asia's largest dialysis service provider. It addresses the critical and growing need for accessible and high-quality renal care through an extensive network of centers.
Company Growth
Founded by: Vikram Vuppala (along with co-founders) in 2009, based in Hyderabad.
Scale (As of Sep 30, 2025):
Clinic Network: Operates 519 clinics globally, including 51 in international markets (Philippines, Uzbekistan, Nepal).
The Nephrocare Health IPO is expected to open in December, 2025, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for Nephrocare Health IPO is ₹438.00 - ₹460.00 per share.
As per market sources, Nephrocare Health IPO GMP is currently ₹40.00. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Nephrocare Health IPO stands at 9.15x overall.
The listing date for Nephrocare Health IPO is December 17, 2025.
No comments yet. Be the first to comment!
